Vigonvita Life Sciences Co., Ltd. (HKG:2630)

Vigonvita Life Sciences Statistics

Total Valuation

HKG:2630 has a market cap or net worth of HKD 14.60 billion. The enterprise value is 15.05 billion.

Market Cap	14.60B
Enterprise Value	15.05B

Important Dates

The next confirmed earnings date is Tuesday, March 31, 2026.

Earnings Date	Mar 31, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2630 has 167.60 million shares outstanding.

Current Share Class	66.68M
Shares Outstanding	167.60M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	63.04%
Owned by Institutions (%)	0.62%
Float	42.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,159.35
PB Ratio	97.72
P/TBV Ratio	143.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-66.90
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-75.83

Financial Position

The company has a current ratio of 0.49, with a Debt / Equity ratio of 2.97.

Current Ratio	0.49
Quick Ratio	0.46
Debt / Equity	2.97
Debt / EBITDA	n/a
Debt / FCF	-2.23
Interest Coverage	-12.60

Financial Efficiency

Return on equity (ROE) is -132.51% and return on invested capital (ROIC) is -23.88%.

Return on Equity (ROE)	-132.51%
Return on Assets (ROA)	-18.16%
Return on Invested Capital (ROIC)	-23.88%
Return on Capital Employed (ROCE)	-50.44%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.02
Inventory Turnover	1.11

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	105.84
200-Day Moving Average	n/a
Relative Strength Index (RSI)	36.58
Average Volume (20 Days)	100,480

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2630 had revenue of HKD 12.59 million and -224.97 million in losses. Loss per share was -1.55.

Revenue	12.59M
Gross Profit	3.71M
Operating Income	-216.73M
Pretax Income	-231.61M
Net Income	-224.97M
EBITDA	-194.99M
EBIT	-216.73M
Loss Per Share	-1.55

Balance Sheet

The company has 129.13 million in cash and 443.17 million in debt, with a net cash position of -314.04 million or -1.87 per share.

Cash & Cash Equivalents	129.13M
Total Debt	443.17M
Net Cash	-314.04M
Net Cash Per Share	-1.87
Equity (Book Value)	149.38M
Book Value Per Share	24.10
Working Capital	-173.24M

Cash Flow

In the last 12 months, operating cash flow was -115.84 million and capital expenditures -82.66 million, giving a free cash flow of -198.50 million.

Operating Cash Flow	-115.84M
Capital Expenditures	-82.66M
Depreciation & Amortization	23.14M
Net Borrowing	95.47M
Free Cash Flow	-198.50M
FCF Per Share	-1.18

Margins

Gross Margin	29.47%
Operating Margin	-1,721.30%
Pretax Margin	-1,839.44%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HKG:2630 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-1.54%
FCF Yield	-1.36%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2630 has an Altman Z-Score of -1.59 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.59
Piotroski F-Score	1